Market
Dexcom reports 15% YoY revenue uptick in Q1 yet maintains prior FY26 outlook
Dexcom reported 15% year-over-year revenue growth in Q1 but chose not to raise its full-year FY26 guidance, citing geopolitical uncertainties. The continuous glucose monitoring vendor maintained its prior outlook despite the stronger-than-expected quarterly performance.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network